查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198700

泌尿動力學設備市場——增長、趨勢和預測 (2023-2028)

Urodynamic Equipment Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，泌尿動力學設備市場預計將以 6.3% 的複合年增長率增長。

COVID-19 對泌尿動力學設備市場產生了重大影響。 政府的封鎖和限制減少了泌尿科服務，包括門診預約、門診檢查和治療以及泌尿外科手術。 例如，從 2022 年 8 月發表在 European Urology 上的一篇文章中，沙特觀察到 28% 的門診就診、30% 的門診調查和 31% 的泌尿外科手術被推遲了八週或更長時間。 此外，根據同一消息來源，與惡性疾病相比，良性疾病的泌尿科服務受到的影響更大。 因此，在 COVID-19 大流行期間，泌尿外科診斷和手術的延誤影響了對尿流動力學設備的需求。 然而，政府放鬆管制、恢復泌尿外科服務和外科手術以及增加醫院就診次數預計將增加對尿動力學設備的需求，推動預測期內的市場增長。

泌尿系統疾病和殘疾負擔加重、老年人口增加以及泌尿動力學設備技術進步等因素正在推動市場增長。 膀胱癌、膀胱感染和炎症、腎結石和尿失禁等泌尿系統疾病的患病率上升是市場增長的主要驅動力。 例如，根據 2022 年 6 月發表的一篇文章，尿路感染是全球 16 至 35 歲女性最常見的細菌感染。 根據同一消息來源，每年有 10% 的女性經歷感染，40% 至 60% 或更多的女性一生中至少經歷一次感染。 因此，對尿動力學治療和症狀和疾病診斷的需求不斷增加，市場增長有望進一步加快。

此外，根據國家醫學圖書館發表的一篇文章，到 2022 年 6 月，全球估計每年將有 4.23 億人經歷某種形式的尿失禁 (UI)。 此外，根據 2021 年 2 月發表的一篇文章，大約有二分之一的 50 歲以上女性經歷過尿失禁問題，這被定義為無法控制的小便洩漏。積載被描述為從幾滴到完全意外的任何事情. 因此，預計尿失禁的高患病率將增加對導尿管的需求，以幫助膀胱排空，從而推動市場增長。 此外，老年人尿失禁和其他泌尿系統疾病的患病率較高，對患者的生活質量產生負面影響。 與年齡相關的下尿路變化，如膀胱容量和飽腹感下降、勃起肌收縮力下降、盆底肌阻力下降和殘餘尿量增加，是導致尿失禁在人群中流行的因素之一。增加 此外，據說老年人患尿路結石的風險增加，是因為陰道內的雌激素減少，陰道環境發生變化，更容易發生細菌感染。

此外，公司加大力度開發技術先進的設備和產品也促進了市場增長。 例如，2022 年 3 月，德裡的 Lok Nayak 醫院啟動了一個尿動力學視頻實驗室，提供泌尿道和膀胱的實時成像和即時生物反饋。 該實驗室擁有先進的膀胱動力學檢查設備，有助於管理患有泌尿系統異常和疾病的兒童。 因此，由於上述因素，預計所研究的市場將在預測期內增長。 然而，在預測期內，嚴格的醫療器械驗證監管政策可能會阻礙尿流動力學器械市場的增長。

尿動力學設備市場趨勢

預計在預測期內，尿流部分將佔據重要的市場份額

由於尿失禁等泌尿系統疾病增多、人口老齡化導致慢性病患病率增加以及技術先進的產品等因素，預計尿流動力學設備市場在預測期內將出現顯著增長。

Uroflowmetry 是一種非侵入性診斷測試，用於診斷下尿路症狀。 它測量從體內釋放的尿液量、釋放速率和釋放所需的時間。 它還有助於確定小便時的主要原因或困難。 因此，與其他儀器相比，這些類型的儀器測量尿量和評估導致排尿困難的確切原因和泌尿系統疾病類型的準確性很高。 出於這個原因，許多疑似下尿路功能障礙的患者更喜歡使用它而不是其他設備。

此外，男性良性前列腺增生症 (BPH) 發病率的上升也增加了對尿流□□率檢測的需求，預計這將在預測期內增加該細分市場的增長。 例如，國家生物技術信息中心 2021 年 7 月發表的一篇論文發現，BPH 的患病率在 60 多歲的男性中高達 50% 至 60%，在 70 歲以上的男性中高達 80% 至 90%。事情得到證實。 此外，越來越多的企業在開發安全有效的診斷測試以測量人群泌尿系統狀況方面的活動也有助於市場增長。 例如，2021 年 11 月，醫療設備製造商 Oruba 將推出 Oruflow，這是第一款自動操作的尿流率計，使篩查過程對患者和醫生都衛生、安全、舒適且簡化。它正在銷售。 因此，由於上述因素，預計該行業在預測期內將顯著增長。

預計在預測期內北美將佔據主要市場份額

預計在預測期內，北美將佔據泌尿動力學設備市場的很大份額。 推動市場增長的因素是該地區泌尿系統疾病發病率的增加和泌尿動力學設備技術的不斷進步。 預計該地區不斷增長的老年人口也將成為市場增長的一個因素。 例如，NCBI 於 2021 年 2 月發表的一篇文章證實，尿失禁對女性的影響超過男性，美國 60 歲以上的女性顯著增加。 另外，根據弗雷澤研究所發布的統計數據，到2022年7月，加拿大約有19%的人口將超過65歲，預計到2030年這一數字將達到22.5%。 衰老會增加出現膀胱問題的風險，例如膀胱控制問題、漏尿和尿失禁。 因此，預計在預測期內，對用於診斷和治療泌尿系統疾病的尿動力學設備的需求將會增加。

此外，該地區越來越多的產品批准和產品發布也促進了市場增長。 例如，2021 年 7 月，Gemini Medical Technologies 推出了 MEDKONSULT Medical Technology 的一系列新尿動力學設備。 同樣在 2021 年 2 月，加拿大衛生部批准了 Bactiguard 的帶有溫度傳感器的 TempSensor 導管，以降低重症患者發生導管相關性尿路感染（CAUTI）等繼發感染的風險。 因此，由於上述因素，預計所研究的市場在預測期內將顯著增長。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 增加泌尿系統疾病和病症的負擔
    • 老年人口增加
    • 泌尿動力學裝置技術進展
  • 市場製約因素
    • 嚴格的醫療器械驗證監管政策
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品類型
    • 泌尿動力學裝置
      • 膀胱壓力計
      • 尿流率測量裝置
      • 環境泌尿系統
      • 肌電圖
      • 視頻尿壓計
    • 尿動力學耗材
      • 導尿管
      • 尿流泵和換能器套件
  • 最終用戶
    • 醫院
    • 門診中心
    • 其他最終用戶
  • 按地區細分
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Medtronic Plc
    • Coloplast□
    • Albyn Medical S.L.
    • Boston Scientific Corporation
    • Coopersurgical, Inc.
    • Laborie（Medical Measurement Systems B.V.）
    • Verathon, Inc.（Roper Technologies, Inc.）
    • Karl Storz SE & Co. KG
    • Olympus Corporation
    • Gemini Medical Technologies
    • White Bridge Investments S.p.A（Delta Med S.p.A.）

第7章 市場機會與今後動向

簡介目錄
Product Code: 67745

The urodynamic equipment market is expected to register a CAGR of 6.3% during the forecast period.

COVID-19 had a significant impact on the urodynamic equipment market. The lockdown measures and the restrictions imposed by the government reduced urological services, including outpatient clinic appointments, outpatient investigations and treatments, and urological surgery. For instance, from an article published in European Urology in August 2022, it has been observed that 28% of outpatient clinics, 30% of outpatient investigations, and 31% of urological surgeries were delayed for more than eight weeks in Saudi Arabia. In addition, as per the same source, urological services for benign conditions were more affected as compared to malignant conditions. Thus, delayed urological diagnostic and surgical procedures have impacted the demand for urodynamic equipment during the COVID-19 pandemic. However, relaxed government restrictions, resumed urological services and surgical procedures, as well as increased hospital visits, are expected to increase the demand for urodynamic equipment, which is anticipated to fuel market growth over the forecast period.

The factors such as the increasing burden of urologic diseases and disorders, the growing geriatric population, and technological advancements in urodynamic equipment are boosting the market growth. The increasing cases of urologic diseases such as bladder cancer, infection or inflammation of the urinary bladder, kidney stones, urinary incontinence problems, and others among the population is the key factor driving market growth. For instance, as per an article published in June 2022, urinary tract infections are the most common bacterial infections in women between the ages of 16 and 35 years globally. As per the same source, 10% of women experience an infection each year, and more than 40% to 60% experience an infection at least once in their lifetimes. This is expected to increase the need for urodynamic treatment and diagnosis of the condition or diseases, which is further anticipated to fuel market growth.

Additionally, as per an article published by the National Library of Medicine, in June 2022, an estimated 423 million people experience some form of urinary incontinence (UI) worldwide every year. Also, according to an article published in February 2021, nearly 1 in 2 women over the age of 50 experience problems with urinary incontinence, which is the uncontrolled leaking of pee and can range from a few drops of leakage to a full accident. Thus, the high prevalence of UI among the population is expected to raise the need for urinary catheters that helps in draining the bladder, hence propelling the market growth. Furthermore, the prevalence of urinary incontinence and other urological diseases is higher in elderly patients and has a negative impact on their quality of life. The changes associated with aging in the lower urinary system, such as decreased bladder capacity and feeling of fullness, decreased rate of detrusor muscle contraction, decreased pelvic floor muscle resistance, and increased residual urine volume, are some of the factors increasing the prevalence of urinary incontinence among people. For instance, elderly women have a greater risk for UTIs due to lower amounts of vaginal estrogen that change the vaginal climate, resulting in bacterial infections.

Moreover, the increasing company initiatives in developing technologically advanced equipment and products are also contributing to market growth. For instance, in March 2022, the Lok Nayak Hospital, Delhi, inaugurated a urodynamic video lab that provides real-time pictures of the urinary tract and bladder as well as immediate biofeedback. The lab has advanced equipment for studying urinary bladder dynamics, which helps in managing children with urological anomalies and diseases. Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. However, the stringent regulatory policies for the validation of medical devices are likely to hinder the growth of the urodynamic equipment market over the forecast period.

Urodynamic Equipment Market Trends

The Uroflowmetry Equipment Segment is Expected to Hold Significant Market Share in the Market Over the Forecast Period

The uroflowmetry equipment segment is expected to witness significant growth in the urodynamic equipment market over the forecast period owing to factors such as the increasing burden of urological diseases such as urinary incontinence, rising chronically ill patients with the growing geriatric population, and technologically advanced products.

Uroflowmetry is a non-invasive diagnostic test used to diagnose patients with lower urinary tract symptoms. It measures the volume of urine released from the body, the speed with which it is released, and how long the release takes. It also aids in identifying the main cause and difficulties patient encounters while urinating. Thus, the accuracy in measuring the urine volume and assessing the exact reason and type of urological disease that causes urinary difficulties in the patients is high among these types of equipment as compared to other devices. This makes it more preferred, for most of the patients with suspected lower urinary tract dysfunction, over other devices.

Additionally, the rising incidences of benign prostate hyperplasia (BPH) condition in men also increases the need for uroflowmetry tests, which is expected to augment the segment's growth over the forecast period. For instance, from an article published by the National Center for Biotechnology Information in July 2021, it has been observed that the prevalence of BPH was 50% to 60% high in males in their 60s and 80% to 90% in those over 70 years of age. Furthermore, the increasing company activities in developing safe and effective diagnostic tests for measuring the urological condition among the population is also contributing to market growth. For instance, in November 2021, Oruba, a medical device company, launched the first self-operating uroflowmeter, Oruflow, that makes the screening procedure hygienic, safe, comfortable, and streamlined for both patients and physicians. Thus, owing to the aforementioned factors, the studied segment is expected to grow significantly during the forecast period.

North America is Anticipated to Hold a Major Share in the Market Over the Forecast Period

North America is expected to hold a significant share of the urodynamic equipment market over the forecast period. The factors attributed to the market growth are the increasing incidences of urological diseases and rising technological advancements in urodynamic equipment in the region. In addition, the rising geriatric population in the region is also expected to increase market growth. For instance, according to an article published by NCBI, in February 2021, it has been observed that urinary incontinence affects women disproportionately more than males and is significantly increased among women aged 60 years and older in the United States. Also, as per statistics published by the Fraser Institute, in July 2022, about 19% of the population living in Canada was aged 65 years and above, and this number is projected to reach 22.5% by 2030. Aging increases the risk of bladder problems such as bladder control issues and leakage or urinary incontinence. Thus, this is expected to increase the demand for urodynamic equipment for diagnosing and treating urological diseases over the forecast period.

Furthermore, the increasing product approvals and product launches in the region are also contributing to market growth. For instance, in July 2021, Gemini Medical Technologies launched a new line of urodynamics equipment by MEDKONSULT Medical Technology. Also, in February 2021, Health Canada approved Bactiguard's TempSensor catheter with a temperature sensor that reduces the risk of secondary infections such as catheter-associated urinary tract infection (CAUTI) in critically ill patients. Thus, owing to the aforementioned factors, the studied market is expected to grow significantly during the forecast period.

Urodynamic Equipment Market Competitor Analysis

The urodynamic equipment market is moderately competitive and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. And some prominent players are vigorously engaging in collaborations, acquisitions, and launching new products with other companies to consolidate their market positions across the globe. Some of the companies that are currently dominating the market are Medtronic Plc, Coloplast​, Albyn Medical S.L., Boston Scientific Corporation, Coopersurgical, Inc., Medical Measurement Systems B.V.​, Verathon, Inc. (Roper Technologies, Inc.), Karl Storz SE & Co. KG, and Olympus Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Urologic Diseases and Disorders
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Technological Advancements in Urodynamic Equipment
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies For Validation of Medical Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Urodynamic Equipment
      • 5.1.1.1 Cystometer
      • 5.1.1.2 Uroflowmetry Equipment
      • 5.1.1.3 Ambulatory Urodynamic Systems
      • 5.1.1.4 Electromyograph
      • 5.1.1.5 Video Urodynamic Systems
    • 5.1.2 Urodynamic Consumables
      • 5.1.2.1 Urodynamic Catheters
      • 5.1.2.2 Urodynamic Pumps and Transducer Sets
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Centers
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic Plc
    • 6.1.2 Coloplast​
    • 6.1.3 Albyn Medical S.L.
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 Coopersurgical, Inc.
    • 6.1.6 Laborie (Medical Measurement Systems B.V.)
    • 6.1.7 Verathon, Inc. (Roper Technologies, Inc.)
    • 6.1.8 Karl Storz SE & Co. KG
    • 6.1.9 Olympus Corporation
    • 6.1.10 Gemini Medical Technologies
    • 6.1.11 White Bridge Investments S.p.A (Delta Med S.p.A.)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS